(Q37311065)

English

Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages

scientific article published on December 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

1 reference

Europe PubMed Central

Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

immunosuppression

1 reference

based on heuristic

inferred from title

author name string

Robert A Brodsky

1

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Richard J Jones

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

publication date

1 December 2008

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

41

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

596-600

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

6 September 2017

High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

6 September 2017

Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

6 September 2017

Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

6 September 2017

Aplastic anaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

6 September 2017

Genetic dissection of retinoid dehydrogenases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

6 September 2017

Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

6 September 2017

Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

6 September 2017

High-dose cyclophosphamide for severe systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

14 September 2017

Recovery of hematologic competence without engraftment following attempted bone marrow transplantation for aplastic anemia: Report of a case with diffusion chamber studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

28 September 2017

Assessment of aldehyde dehydrogenase in viable cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

28 September 2017

Aplastic anaemia treated by marrow transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

26 June 2018

Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

26 June 2018

Autologous marrow recovery following allogeneic marrow transplantation in a patient with severe aplastic anemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

26 June 2018

Recovery from aplastic anemia following attempted marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

26 June 2018

Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

2 September 2018

Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

2 September 2018

High-dose cyclophosphamide as salvage therapy for severe aplastic anemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

2 September 2018

High dose cyclophosphamide for severe refractory myasthenia gravis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

2 September 2018

Remission of severe autoimmune enteropathy after treatment with high-dose cyclophosphamide.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

2 September 2018

High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

2 September 2018

Treatment of refractory myasthenia: "rebooting" with high-dose cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

2 September 2018

High-dose cyclophosphamide for refractory autoimmune hemolytic anemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

2 September 2018

Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100525

2 September 2018

High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18958751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of severe aplastic anemia using high-dose cyclophosphamide alone in China

1 reference

https://pubmed.ncbi.nlm.nih.gov/18958751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elimination of alloantibodies by immunoablative high-dose cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/18958751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose cyclophosphamide in the treatment of severe aplastic anemia in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/18958751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose cyclophosphamide without stem-cell rescue for refractory CIDP

1 reference

https://pubmed.ncbi.nlm.nih.gov/18958751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recovery from aplastic anemia after treatment with cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/18958751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18958751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18958751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18958751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous hematopoietic stem cell transplantation for autoimmune diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18958751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1080/08916930802197206

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37311065&oldid=1700085902"